Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "O2k-Publications: Topics"

From Bioblast
Line 148: Line 148:
! MitoPedia
! MitoPedia
! Number
! Number
! Comment
|-
|-
|style="text-align:left"|1
|style="text-align:left"|1
Line 154: Line 155:
|style="text-align:left"|[[F-pathway control state]]
|style="text-align:left"|[[F-pathway control state]]
|{{#ask:[[Category:Publications]][[Pathways::F]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::F]] |format=count}}  
|style="text-align:left"|Fatty acid oxidation, level 5
|-  
|-  
|style="text-align:left"|2
|style="text-align:left"|2
Line 160: Line 162:
|style="text-align:left"|[[N-pathway control state]]
|style="text-align:left"|[[N-pathway control state]]
|{{#ask:[[Category:Publications]][[Pathways::N]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::N]] |format=count}}  
|style="text-align:left"|NADH-linked, level 4
|-  
|-  
|style="text-align:left"|3
|style="text-align:left"|3
Line 166: Line 169:
|style="text-align:left"|[[S-pathway control state]]
|style="text-align:left"|[[S-pathway control state]]
|{{#ask:[[Category:Publications]][[Pathways::S]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::S]] |format=count}}  
|style="text-align:left"|Succinate-linked, level 3
|-  
|-  
|style="text-align:left"|4
|style="text-align:left"|4
Line 172: Line 176:
|style="text-align:left"|[[Gp-pathway control state]]
|style="text-align:left"|[[Gp-pathway control state]]
|{{#ask:[[Category:Publications]][[Pathways::Gp]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::Gp]] |format=count}}  
|style="text-align:left"|Glycerophosphate-linked, level 3
|-  
|-  
|style="text-align:left"|5
|style="text-align:left"|5
Line 178: Line 183:
|style="text-align:left"|[[DQ-pathway control state]]
|style="text-align:left"|[[DQ-pathway control state]]
|{{#ask:[[Category:Publications]][[Pathways::DQ]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::DQ]] |format=count}}  
|style="text-align:left"|Duorquinol-linked, level 2
|-  
|-  
|style="text-align:left"|6
|style="text-align:left"|6
Line 184: Line 190:
|style="text-align:left"|[[Complex IV single step]]
|style="text-align:left"|[[Complex IV single step]]
|{{#ask:[[Category:Publications]][[Pathways::CIV]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::CIV]] |format=count}}  
|style="text-align:left"|Ascorbate & TMPD, level 1
|-  
|-  
|style="text-align:left"|7
|style="text-align:left"|7
Line 190: Line 197:
|style="text-align:left"|[[NS-pathway control state]]
|style="text-align:left"|[[NS-pathway control state]]
|{{#ask:[[Category:Publications]][[Pathways::NS]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::NS]] |format=count}}  
|style="text-align:left"|Convergent CI- and CII-linked electron flow to the [[Q-junction]] 
|-  
|-  
|style="text-align:left"|8
|style="text-align:left"|8
Line 196: Line 204:
|style="text-align:left"|[[Other combinations-pathway control state]]
|style="text-align:left"|[[Other combinations-pathway control state]]
|{{#ask:[[Category:Publications]][[Pathways::Other combinations]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::Other combinations]] |format=count}}  
|style="text-align:left"|
|-  
|-  
|style="text-align:left"|9
|style="text-align:left"|9
Line 202: Line 211:
|style="text-align:left"|[[Residual oxygen consumption]]
|style="text-align:left"|[[Residual oxygen consumption]]
|{{#ask:[[Category:Publications]][[Pathways::ROX]] |format=count}}  
|{{#ask:[[Category:Publications]][[Pathways::ROX]] |format=count}}  
|style="text-align:left"|[[Residual oxygen consumption]]
|-  
|-  
|}
|}

Revision as of 14:02, 9 November 2016

                



O2k-Publications: Topics

Mitochondria and cell research
O2k-Publications: chronological
Publications in the MiPMap


See also » O2k-Publications - chronological: 4695


O2k-Publications in the MiPMap: MiParea


Pathological states

Alphabetical order

•• Aging;senescence •• Alzheimer's •• Autism •• Cancer •• Cardiovascular •• COPD •• Diabetes •• Inherited •• Infectious •• Myopathy •• Neurodegenerative •• Obesity •• Parkinson's •• Sepsis


Stress conditions

Alphabetical order

•• Cell death •• Cryopreservation •• Hypoxia •• Ischemia-reperfusion injury and preservation •• Mitochondrial disease;degenerative disease and defect •• Oxidative stress;RONS •• Permeability transition •• Temperature: hypothermia; hyperthermia


Organisms

Mammals and models
Non-mammals
  • O2k-Publications: Organisms
  • Amphibians •• Annelids •• Birds •• Crustaceans •• Eubacteria •• Fishes •• Fungi •• Hexapods •• Molluscs •• Nematodes •• Other invertebrates •• Plants •• Protists •• Reptiles


Tissues and cells

Tissues - alphabetical order

•• Fat •• Genital •• Heart •• Kidney •• Liver •• Lung;Gill •• Nervous system •• Skeletal muscle

Cell types - alphabetical order

•• Blood cells •• Endothelial;epithelial;mesothelial cell •• Fibroblast •• Islet cell;pancreas;thymus •• Lymphocyte •• Platelet •• Stem cells

Cell lines - alphabetical order

•• CHO •• HEK •• HeLa •• Neuroblastoma •• HUVEC •• Macrophage-derived cell lines


Preparations


Enzymes

Alphabetical order

•• Adenine nucleotide translocase •• Complex I •• Complex II;succinate dehydrogenase •• Complex III •• Complex IV;cytochrome c oxidase •• Complex V;ATP synthase •• Inner mt-membrane transporter •• Marker enzyme •• Supercomplex •• TCA cycle and matrix dehydrogenases •• Uncoupling protein


Regulation

Alphabetical order

•• ADP •• ATP production •• Aerobic glycolysis •• Amino acid •• Calcium •• Coupling efficiency;uncoupling •• Cyt c •• Fatty acid •• Flux control •• Inhibitor •• Ion;substrate transport •• mt-Membrane potential •• Oxygen kinetics •• Q-junction effect •• Redox state •• Substrate •• Temperature •• Threshold;excess capacity •• Uncoupler


Coupling control states

•• OXPHOS •• ROUTINE •• ETS •• LEAK


Pathway control states

# O2k-Publications Number MitoPedia Number Comment
1 F 607 F-pathway control state 751 Fatty acid oxidation, level 5
2 N 2466 N-pathway control state 2614 NADH-linked, level 4
3 S 1679 S-pathway control state 1787 Succinate-linked, level 3
4 Gp 156 Gp-pathway control state 182 Glycerophosphate-linked, level 3
5 DQ 26 DQ-pathway control state 31 Duorquinol-linked, level 2
6 CIV 700 Complex IV single step 728 Ascorbate & TMPD, level 1
7 NS 1573 NS-pathway control state 1629 Convergent CI- and CII-linked electron flow to the Q-junction
8 Other combinations 131 Other combinations-pathway control state 147
9 ROX 1516 Residual oxygen consumption 1568 Residual oxygen consumption


MiPMap combinations - examples

Examples for specific combinations
Browse data


O2k-Manuals and protocols and specific instrumental applications